Unlock the full potential of your medical coding capabilities with the CPT® Advanced Coding Pack from the American Medical Association (AMA). Designed for professional medical coders, auditors, and billers like you, this comprehensive suite of resources provides everything you need to navigate the complexities of the CPT code set with confidence and precision.
Advanced Coding Pack includes:
CPT Assistant - Newsletter with official education and guidance
CPT Knowledge Base - Commonly asked coding questions answered by the experts
CPT Vignettes - Comprehensive clinical examples.
Add to your Find-A-Code subscription for $300 / person
Learn More and Subscribe
2A02.4 Benign neoplasm of spinal cord International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01 postcoordination Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.
Specific anatomy - multiple selections are allowed [select] XA0V83 Spinal cord – XA1SP1 Cervical spinal cord –– XA2K06 C1 level –– XA7852 C2 level –– XA3JF5 C3 level –– XA2MQ3 C4 level –– XA3JA6 C5 level –– XA4LT0 C6 level –– XA3NV2 C7 level –– XA8965 C8 level – XA6Z51 Thoracic spinal cord –– XA17G6 T1 level –– XA6GU9 T2 level –– XA7U15 T3 level –– XA5UF4 T4 level –– XA0D58 T5 level –– XA5Q83 T6 level –– XA79E1 T7 level –– XA0N76 T8 level –– XA5T86 T9 level –– XA4QU1 T10 level –– XA9DV3 T11 level –– XA6FB9 T12 level – XA8PP5 Lumbar spinal cord –– XA6TL5 L1 level –– XA8X63 L2 level –– XA57M0 L3 level –– XA1ZV5 L4 level –– XA86M5 L5 level – XA85J0 Sacral spinal cord –– XA3407 S1 level –– XA8EL3 S2 level –– XA1VA6 S3 level –– XA2EF6 S4 level –– XA4L09 S5 level – XA5QM0 Medullary cavity – XA2FQ1 Conus medullaris – XA84W1 Cauda equina Histopathology - only one may be selected [select] XH2ZQ0 Adenocarcinoma with mixed subtypes XH4NS3 Venous haemangioma XH9HB7 Lobular carcinoma, pleomorphic XH6JN6 Medulloblastoma with extensive nodularity XH2XP8 Malignant peripheral nerve sheath tumour XH3C14 Sex cord-stromal tumour, benign XH0E35 Chronic monocytic leukaemia XH0349 Adenocarcinoma, intestinal type XH5AW4 Haemangioma, NOS XH1146 Juvenile carcinoma of breast XH85M7 Medulloblastoma, SHH activated, NOS XH5C30 Melanotic MPNST XH69N5 Signet-ring stromal tumour XH6JX2 Eosinophilic leukaemia XH8B45 Solid carcinoma, NOS XH37N4 Myointimoma XH8TH6 Cystic hypersecretory carcinoma XH8SH6 CNS embryonal tumour, NOS XH3NT0 Melanotic psammomatous MPNST XH35B3 Microcystic stromal tumour XH5JT8 Monocytic leukaemia, NOS XH8DS0 Neuroendocrine tumour, NOS XH1JJ2 Angiofibroma, NOS XH89C3 Central primitive neuroectodermal tumour XH8HF5 MPNST with glandular differentiation XH34A0 Thecoma, NOS XH1S60 Subacute monocytic leukaemia XH8LX8 Neuroendocrine carcinoma, low grade XH23S6 Verrucous keratotic haemangioma XH3EX1 Medulloblastoma, WNT-activated, classic XH7HR8 MPNST with mesenchymal differentiation XH40J2 Luteoma, NOS XH7DF6 Subacute myeloid leukaemia XH55D7 Neuroendocrine carcinoma, well-differentiated XH4E06 Cellular angiofibroma XH9HV0 Epithelial tumour, benign XH5163 Medulloblastoma, WNT-activated, Large cell type XH3W53 MPNST with perineurial differentiation XH2U25 Granulosa cell tumour of the testis, juvenile XH8AA5 Acute myeloid leukaemia, NOS XH9LV8 Neuroendocrine tumor, grade 1 XH73S9 Giant cell angiofibroma XH1TD2 Tumourlet, benign XH2FW8 Medulloblastoma, WNT-activated, Anaplastic type XH4V81 Malignant peripheral nerve sheath tumour, epithelioid XH5XQ2 Leydig cell tumour of the ovary, NOS XH4M02 Acute myeloid leukemia with biallelic mutation of CEBPA XH7NM1 Enterochromaffin cell carcinoid XH2EX4 Acquired tufted haemangioma XH65S3 Epithelioma, benign XH1SH4 Medulloblastoma, SHH-activated and TP53-mutant XH88C2 Neurilemoma, malignant XH9LH4 Hilus cell tumour XH74W8 Acute myeloid leukaemia with mutated NPM1 XH0U20 Neuroendocrine carcinoma, NOS XH4KP7 Angiokeratoma XH0M86 Focal nodular hyperplasia XH87Q5 Medulloblastoma, non-WNT/non-SHH XH2VV8 Malignant peripheral nerve sheath tumour with rhabdomyoblastic differentiation XH9XY1 Lipid cell tumour of ovary XH4XG8 Chronic myeloid leukaemia, NOS XH7F73 Neuroendocrine carcinoma, moderately differentiated XH8SM9 Cutaneous epithelioid angiomatoid nodule XH51C5 Embryonal tumours with multilayered rosettes with C19MC alteration XH31C8 Perineurioma, malignant XH1PE9 Masculinovoblastoma XH9Y46 Acute myeloid leukaemia with t(6;9)(p23;q34); DEK-NUP214 XH24W2 Lepidic adenocarcinoma XH8KN7 Atypical vascular lesion XH5NV6 Carcinoma in situ, NOS XH0KZ2 Embryonal tumour with multilayered rosettes, NOS XH9RV1 Adrenal rest tumour XH1A50 Acute promyelocytic leukaemia, t(15;17)(q22;q11-12) XH3QM0 Minimally invasive adenocarcinoma, Non-mucinous XH9Q71 Cherry hemangioma XH5538 Cerebellar sarcoma, NOS XH2637 Melanotic schwannoma XH78Y4 Acute myelomonocytic leukaemia XH4302 Adenoid cystic carcinoma XH88L5 Sinusoidal hemangioma XH56X7 Carcinoma with osteoclast-like giant cells XH8R14 Medullomyoblastoma XH44E8 Androblastoma, malignant XH2KE3 Acute myeloid leukaemia with inv(3)(q21;q26.2) or t(3.3)(q21;q26.2); RPN1-EVI1 XH2098 Minimally invasive adenocarcinoma, Mucinous XH9UU3 Microvenular hemangioma XH63D2 Carcinoma, NOS XH7Y86 Supratentorial PNET XH1QG7 Granulosa cell carcinoma XH7MR1 Acute basophilic leukaemia XH6LV9 Papillary adenocarcinoma, NOS XH9NB0 Glomeruloid hemangioma XH3XZ6 Giant cell and spindle cell carcinoma XH5PR7 Large cell medulloblastoma XH6K00 Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) XH97Z8 Granulosa cell tumour, sarcomatoid XH3PA4 Acute myeloid leukaemia with abnormal marrow eosinophils XH95U1 Villoglandular carcinoma XH6RP8 Spindle cell hemangioma XH1JZ2 Giant cell carcinoma XH0H95 Anaplastic medulloblastoma XH6KA6 Gangliocytoma XH29E0 Sertoli-Leydig cell tumour, poorly differentiated XH90G0 Acute myeloid leukaemia, minimal differentiation XH6QG3 Micropapillary carcinoma, NOS XH27G6 Congenital hemangioma, NOS XH00N7 Glassy cell carcinoma XH8UC5 Giant cell glioblastoma XH03L9 Ganglioneuroma XH3BT2 Sertoli-Leydig cell tumour, poorly differentiated, with heterologous elements XH5AH8 Acute myeloid leukaemia without maturation XH4MW7 Micropapillary adenocarcinoma XH6RC4 Congenital hemangioma, rapidly involuting XH4QU2 Large cell carcinoma with rhabdoid phenotype XH0RY1 Classic medulloblastoma XH6LR5 Ganglioneuromatosis XH4KB9 Sertoli-Leydig cell tumour, sarcomatoid XH1XJ9 Acute myeloid leukaemia with maturation XH7KL6 Pituitary carcinoma, NOS XH5427 Congenital hemangioma, non-involuting XH0NL5 Large cell neuroendocrine carcinoma XH7PN5 Desmoplastic nodular medulloblastoma XH28W9 Medulloepithelioma, benign XH1JS6 Thecoma, malignant XH2AB7 Chronic myelogenous leukaemia, BCR/ABL positive XH6L02 Clear cell adenocarcinoma, NOS XH8PD3 Hobnail hemangioma XH35G0 Pleomorphic carcinoma XH3904 Papillary tumour of the pineal region XH8NQ6 Pacinian tumour XH0GA5 Adult granulosa cell tumor of ovary XH21X5 Atypical chronic myeloid leukaemia, BCR/ABL negative XH5085 Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome-associated renal cell carcinoma XH4LY5 Lobular capillary hemangioma XH92T7 Polygonal cell carcinoma XH2C49 Diffuse astrocytoma, IDH-wildtype XH5AV1 Retinocytoma XH7DV5 Granulosa cell tumour, adult type XH26U9 Atypical chronic myeloid leukaemia, Philadelphia chromosome (Ph1) negative XH1442 MiT Family translocation carcinomas XH35M3 Pseudosarcomatous carcinoma XH2BA5 Epithelioid glioblastoma XH5NR7 Teratoid medulloepithelioma, benign XH9G68 Leydig cell tumour, malignant XH9NE2 Acute monocytic leukaemia XH8EN1 Succinate dehydrogenase deficient renal cell carcinoma XH4E71 Haemangioendothelioma, malignant XH1YN3 Carcinoma, metastatic, NOS XH0ZP6 Medulloblastoma, WNT-activated, NOS XH4L39 Steroid cell tumour, malignant XH1K97 Acute monoblastic and monocytic leukaemia XH07X3 Alveolar adenocarcinoma XH6264 Hemangiosarcoma XH8D74 Carcinomatosis XH5XD3 Medulloblastoma, group 3 XH7ZQ4 Atypical teratoid/rhabdoid tumour XH7051 Sertoli cell carcinoma XH64R4 Acute myeloid leukaemia with myelodysplasia-related changes XH05V6 Renal cell carcinoma, NOS XH36A5 Kaposi sarcoma XH4P61 Epithelioma, malignant XH25R4 Medulloblastoma, group 4 XH2GG3 Ganglioglioma, anaplastic XH3CX5 Acute myeloid leukaemia, t(8;21)(q22;q22) XH3Z08 Renal cell carcinoma, unclassified XH6FJ5 Kupffer cell sarcoma XH45J4 Large cell carcinoma, NOS XH39Z7 Astrocytoma, anaplastic, IDH-wildtype XH77W7 Ganglioneuroblastoma XH2KH2 Granulosa cell tumour, juvenile XH1E41 Acute myeloid leukaemia, 11q23 abnormalities XH0RU3 Acquired cystic disease associated renal cell carcinoma XH3C78 Intravascular bronchial alveolar tumour XH1YY4 Carcinoma, undifferentiated, NOS XH17F8 Diffuse low-grade glioma, MAPK pathway-altered XH0RB7 Ganglioneuroblastoma, intermixed XH37K7 Granulosa cell-theca cell tumour XH6AQ7 Myeloid leukaemia associated with Down Syndrome XH7K79 Tubulocystic renal cell carcinoma XH36H7 Intimal sarcoma XH57U9 Carcinoma, anaplastic, NOS XH2SS9 Diffuse hemispheric glioma, H3 G34-mutant XH6JM6 Retinoblastoma, differentiated XH0Q64 Gynandroblastoma XH4750 Acute megakaryoblastic leukaemia XH1VB1 Hybrid oncocytic chromophobe tumour XH9GF8 Epithelioid haemangioendothelioma, NOS XH2855 Nuclear protein in testis (NUT) associated carcinoma XH4Q01 Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype XH49K9 Spongioneuroblastoma XH9E02 Large cell calcifying Sertoli cell tumour XH16K4 Acute myeloid leukaemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 XH3Z50 Follicular carcinoma, NOS XH3RZ4 Spindle cell carcinoma, NOS XH4ZM8 Infant-type hemispheric glioma XH0AM8 Teratoid medulloepithelioma XH0UP7 Sertoli-Leydig cell tumour of intermediate differentiation XH7045 Therapy related myeloid neoplasm XH9508 Endometrioid adenocarcinoma, ciliated cell variant XH4SY7 Papillary intralymphatic angioendothelioma XH0YB0 Small cell carcinoma, NOS XH12D2 Pilocytic astrocytoma XH70S0 CNS ganglioneuroblastoma XH6FQ9 Sertoli-Leydig cell tumour, NOS XH6Z50 Therapy-related acute myeloid leukaemia, alkylating agent related XH0718 Endometrioid adenocarcinoma, secretory variant XH6PA4 Kaposiform haemangioendothelioma XH9SY0 Small cell neuroendocrine carcinoma – XH29Q5 Pilomyxoid astrocytoma XH85Z0 Neuroblastoma, NOS XH8U56 Sertoli-Leydig cell tumour, intermediate differentiation, with heterologous elements XH4EJ0 Therapy-related acute myeloid leukaemia, epipodophyllotoxin-related XH4KH2 Adrenal cortical carcinoma XH2PS0 Spindle cell haemangioendothelioma XH28J9 Oat cell carcinoma XH2WK5 Medulloepithelioma, NOS XH6XB6 Sertoli-Leydig cell tumour, retiform XH3L40 Myeloid sarcoma XH0SD2 Endometrioid adenocarcinoma, NOS XH26F6 Pseudomyogenic (epithelioid sarcoma-like) haemangioendothelioma XH3T00 Small cell carcinoma, fusiform cell XH41C5 Angiocentric glioma XH9FP2 Neuroepithelioma, NOS XH3PN1 Sertoli-Leydig cell tumour, retiform, with heterologous elements XH1075 Acute panmyelosis with myelofibrosis XH51K1 Neuroendocrine tumour, grade 2 XH64U8 Retiform haemangioendothelioma XH6GK0 Small cell carcinoma, intermediate cell XH3Y57 Atypical choroid plexus papilloma XH8WC7 Retinoblastoma, NOS XH5BV8 Sex cord tumour with annular tubules XH6FZ7 Acute myeloid leukemia with BCR-ABL1 XH09B7 Endometrioid cystadenocarcinoma XH8D24 Composite haemangioendothelioma XH8ZR8 Small cell carcinoma, hypercalcaemic type XH7M44 Desmoplastic infantile astrocytoma XH7KP6 Retinoblastoma, undifferentiated XH5PC7 Sex cord-gonadal stromal tumour, incompletely differentiated XH1EK4 Acute myeloid leukemia with mutated RUNX1 XH6KR7 Endometrioid adenofibroma, malignant XH2L98 Haemangioendothelioma, NOS XH7YE3 Combined small cell carcinoma XH6TQ7 Desmoplastic infantile ganglioglioma XH1YZ7 Retinoblastoma, diffuse XH19F9 Sex cord-gonadal stromal tumour, mixed forms XH0GS9 Adenocarcinoma, endocervical type XH6810 Haemangioblastoma XH0793 Combined small cell-adenocarcinoma XH0B58 Gliofibroma XH09A4 Olfactory neurogenic tumour XH9G57 Sex cord-gonadal stromal tumour, NOS XH67W4 Transient abnormal myelopoiesis XH8SF8 Islet cell adenomatosis XH6FK9 Combined small cell-large cell carcinoma XH6738 Mixed subependymoma-ependymoma XH7QE0 Olfactory neurocytoma XH8033 Stromal tumour with minor sex cord elements XH43E4 Perihilar cholangiocarcinoma XH9ZD2 Combined small cell-squamous cell carcinoma XH15U1 Myxopapillary ependymoma XH2Y49 Olfactory neuroepithelioma XH8CW8 Uterine tumour resembling ovarian sex cord tumour XH86N4 Chronic myelomonocytic leukaemia, NOS XH4BY1 Islet cell adenoma XH9ZB2 Adenolymphoma XH1DU4 Non-small cell carcinoma XH1L48 Subependymal giant cell astrocytoma XH50L1 Olfactory neuroblastoma XH0667 Sex cord-stromal tumour, unclassified XH0FC4 Chronic myelomonocytic leukaemia, Type I XH3CU4 Villoglandular variant of endometrioid adenocarcinoma XH1TX5 Mixed squamous cell and glandular papilloma XH26N1 Heterotopia-associated carcinoma XH8FZ9 Subependymoma XH3AV2 CNS embryonal tumor with rhabdoid features XH0U48 Mixed germ cell-sex cord-stromal tumour, NOS XH7HJ7 Chronic myelomonocytic leukaemia, Type II XH5QV8 Pituitary blastoma XH7J33 Lymphadenoma XH90B3 Combined large cell neuroendocrine carcinoma XH59V4 Pituicytoma XH27A8 Mixed germ cell-sex cord-stromal tumour, unclassified XH4QZ1 Juvenile myelomonocytic leukaemia XH0Y80 Follicular carcinoma, encapsulated, angioinvasive XH98Z7 Anaplastic undifferentiated carcinoma XH9HV1 Chordoid glioma XH0C11 Central neurocytoma XH5BN5 Adult granulosa cell tumour of testis XH9MA0 Aggressive NK-cell leukaemia XH46F1 Clear cell renal cell carcinoma, NOS XH2PY4 Adenocarcinoma with squamous metaplasia XH5R16 Dedifferentiated carcinoma XH4101 Chordoid glioma of third ventricle XH2GB0 Cerebellar liponeurocytoma XH0GT2 Androblastoma, NOS XH5J10 Hairy cell leukaemia XH9SA7 Basal cell adenocarcinoma XH7873 Adenosquamous carcinoma XH2BS4 Squamous carcinoma with osteoclast-like giant cells XH5FJ3 Ganglioglioma, NOS XH4H24 Sertoli cell tumour, NOS XH85C2 Endolymphatic sac tumor XH9JP2 Epithelial-myoepithelial carcinoma XH2224 Undifferentiated carcinoma with osteoclast-like giant cells XH2HS1 Extraventricular neurocytoma XH7RD2 Intratubular large cell hyalinizing Sertoli cell neoplasia XH4PB1 Acinar adenocarcinoma of prostate XH7247 Adenocarcinoma with cartilaginous and osseous metaplasia XH09A9 Granular cell tumour, NOS XH3XU4 Papillary glioneuronal tumour XH51L7 Leydig cell tumour of the testis, NOS XH5FJ5 Malignant lymphoma, NOS XH8E54 Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN) XH2QL8 Adenocarcinoma with spindle cell metaplasia XH1N44 Tumourlet, NOS XH2XW8 Granular cell tumour of the sellar region XH2JU8 Rosette-forming glioneuronal tumour XH50P3 Malignant lymphoma, non-Hodgkin, NOS XH5QW8 Neuroendocrine tumour, grade 3 XH6G98 Fibromatosis-like metaplastic carcinoma XH2F27 Retinoblastoma, spontaneously regressed XH5RG7 B cell lymphoma, NOS XH1NL5 Nesidioblastoma XH4GA3 Adenocarcinoma with apocrine metaplasia XH8V95 Alveolar soft part sarcoma XH17Q9 Papilloma, NOS XH9MU1 Lymphosarcoma, NOS XH5XB7 Islet cell carcinoma XH4T39 Adenocarcinoma with neuroendocrine differentiation XH5DX3 Brenner tumour, NOS XH90D3 Granular cell tumour, malignant XH7YQ5 Squamous cell papilloma, inverted XH8226 Malignant lymphoma, diffuse, NOS XH2ST7 Islet cell tumor, NOS XH0RD4 Metaplastic carcinoma, NOS XH4MA6 Intracanalicular fibroadenoma XH8RN4 Balloon cell naevus XH50T2 Squamous cell papilloma, NOS XH5WX8 Malignant lymphoma, non-cleaved cell, NOS XH4SH8 Insulinoma, NOS XH7MV6 Hepatoid adenocarcinoma XH7JU0 Papillary adenofibroma XH27A6 Compound naevus XH4611 Squamous intraepithelial neoplasia, low grade XH51A9 Reticulum cell sarcoma, NOS XH93H8 Gastrinoma XH95Y6 Squamoid eccrine ductal carcinoma XH0N11 Pericanalicular fibroadenoma XH2SJ1 Fibrolipoma – XH8WP0 Inflamed juvenile conjunctival naevus XH50N3 Squamous papillomatosis XH9E18 Hairy cell leukaemia variant XH7JQ0 Parathyroid carcinoma XH8XD1 Endometrioid carcinoma with squamous differentiation XH9HE2 Fibroadenoma, NOS XH0PH8 Fibromyxolipoma XH6DN3 Diffuse melanocytosis XH2Y10 Verrucous papilloma XH1SK1 Malignant lymphoma, lymphocytic, intermediate differentiation, nodular XH9LV7 Basophil carcinoma XH91Y8 Adenofibroma, NOS XH7TB0 Infiltrating angiolipoma XH9035 Dysplastic naevus XH9S34 Anal intraepithelial neoplasia, low grade XH06Q4 Malignant lymphoma, lymphocytic, poorly differentiated, diffuse XH7152 Glucagon-like peptide-producing tumour XH5S99 Cystadenofibroma, NOS XH5GN5 Infiltrating lipoma XH2HG8 Epithelioid and spindle cell naevus XH1W63 Cervical intraepithelial neoplasia, low grade XH9PT6 Malignant lymphoma, small cell, noncleaved, diffuse XH7LW9 L-cell tumour XH4ZH4 Adenomyoma XH5ZB5 Serous adenofibroma, NOS XH3TE0 Intramuscular lipoma XH8ZB4 Hairy naevus XH3Y37 Oesophageal squamous intraepithelial neoplasia (dysplasia), low grade XH2TN1 Malignant lymphoma, small cleaved cell, diffuse XH9ZS8 Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumour XH7ZB1 Atypical polypoid adenomyoma XH6RL8 Serous cystadenofibroma, NOS XH30M7 Pleomorphic lipoma XH5971 Halo naevus XH0S03 Benign keratosis, NOS XH75T5 Splenic B-cell lymphoma/leukaemia, unclassifiable XH4NQ8 Glucagonoma XH6YS4 Benign cystic nephroma XH1VJ0 Seromucinous adenofibroma XH4E98 Spindle cell lipoma XH2MQ5 Dermal naevus XH63L8 Lichen planus-like keratosis XH99V9 Splenic diffuse red pulp small B-cell lymphoma XH2PF0 Enteroglucagonoma XH70N8 Chondroid syringoma XH59X8 Mucinous adenofibroma, NOS XH1PL8 Lipoma, NOS XH1BE4 Magnocellular naevus XH7AQ2 Large cell acanthoma XH3BP6 Composite Hodgkin and non-Hodgkin lymphoma XH72E5 Vipoma XH8C13 Endometrial stromal nodule XH9SM7 Mucinous cystadenofibroma, NOS XH4G31 Thymolipoma XH8CU4 Neuronevus XH36H6 Actinic keratosis XH04Y1 B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma XH5VH0 Somatostatinoma XH3SR2 Ossifying renal tumour XH50P7 Phyllodes tumour, benign XH3C77 Angiolipoma, NOS XH0XH2 Nonpigmented naevus XH8MN8 PUVA keratosis XH1FZ7 Primary cutaneous follicle centre lymphoma XH41P2 Endocrine tumour, functioning, NOS XH2KC1 Pleomorphic adenoma XH4RU1 Giant fibroadenoma XH4VB4 Angiomyolipoma XH4L78 Pigmented naevus, NOS XH5NG4 Arsenical keratosis XH73D5 Monoclonal B-cell lymphocytosis, NOS XH7AG8 ACTH-producing tumour XH3470 Renomedullary interstitial cell tumour XH70H4 Juvenile fibroadenoma XH7WX8 Chondroid lipoma XH02Z5 Melanocytoma, NOS XH13L5 Clear cell acanthoma XH5M35 Monoclonal B-cell lymphocytosis, non-CLL type XH60V1 Medullary thyroid carcinoma XH2E97 Stromal tumour, benign XH5853 Lipofibroadenoma XH17C5 Myelolipoma XH8974 Meningeal melanocytosis XH65S7 Warty dyskeratoma XH3BU6 Bile duct cystadenocarcinoma XH0533 Mixed epithelial and stromal tumour XH7ZU2 Metanephric adenofibroma XH1054 Hibernoma XH1M79 Junctional naevus, NOS XH0949 Seborrhoeic keratosis XH94F7 Hodgkin lymphoma, NOS XH2MW1 Medullary carcinoma with amyloid stroma XH7TJ0 Paediatric cystic nephroma XH8L55 Lipoblastomatosis XH9QV1 Spindle cell naevus, NOS XH7B58 Solar lentigo XH22K3 Classical Hodgkin lymphoma post-transplant lymphoproliferative disease XH8VU6 Poorly differentiated thyroid carcinoma XH5QU1 Adenomyoepithelioma, NOS XH6NJ7 Brenner tumour, malignant XH7QJ7 Blue nevus, NOS XH8CB2 Hodgkin lymphoma, lymphocyte-rich XH4NH4 Pituitary neuroendocrine tumour XH2V57 Adenomyoepithelioma, benign XH7284 Mucinous adenocarcinofibroma XH1C03 Dedifferentiated liposarcoma XH2P88 Pigmented spindle cell naevus of Reed XH2NM8 Bowen disease XH7KX4 Hodgkin disease, lymphocyte predominance, NOS XH2ZA2 Bronchial adenoma, carcinoid XH9T96 Phosphaturic mesenchymal tumour, benign XH75P5 Periductal stromal tumour, low grade XH6R46 Fibroblastic liposarcoma XH79G6 Epithelioid cell naevus XH9CL8 Differentiated VIN XH9NJ5 Hodgkin lymphoma, mixed cellularity, NOS XH5TR7 Adenocarcinoma of lung, mixed mucinous and non-mucinous XH3UD9 Pulmonary hamartoma XH9JC2 Serous adenocarcinofibroma XH7PE7 Inflammatory liposarcoma XH3X84 Cellular blue naevus XH6824 Differentiated PeIN XH7RN9 Hodgkin lymphoma, lymphocyte depletion, NOS XH7GY6 Adenocarcinoma of lung, mucinous XH3CQ8 Myoepithelioma XH6PQ0 Serous cystadenocarcinofibroma XH7Y61 Liposarcoma, well differentiated XH40S8 Naevus spilus XH4JA4 Papillary carcinoma in situ XH7299 Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis XH2035 Bronchiolo-alveolar carcinoma, non-mucinous XH7AA3 Mesenchymoma, benign XH0WW5 Mucinous cystadenocarcinofibroma XH8VG3 Mixed liposarcoma XH81Y1 Deep penetrating naevus XH8YK9 Papillary squamous cell carcinoma, non-invasive XH4E19 Hodgkin lymphoma, lymphocyte depletion, reticular XH6LF9 Carcinoma simplex XH1SP3 Adult cystic nephroma XH8HJ7 Phyllodes tumour, malignant XH3EL0 Myxoid liposarcoma XH0DU8 Combined naevus XH1U36 Squamous cell carcinoma in situ with questionable stromal invasion XH2FG7 Hodgkin lymphoma, nodular lymphocyte predominant XH0XL5 Carcinoma, diffuse type XH2P15 Mesenchymal hamartoma XH25R1 Pleomorphic liposarcoma XH5EL4 Genital naevus XH7WM7 Squamous cell carcinoma in situ, NOS XH13B0 Hodgkin granuloma XH7M15 Cholangiocarcinoma XH1WZ6 Ectomesenchymal chondromyxoid tumour XH2CH8 Brenner tumour, borderline malignancy XH8D43 Sclerosing liposarcoma XH8FS8 Conjunctival naevus XH3EA2 Squamous intraepithelial neoplasia, high grade XH11Y2 Hodgkin sarcoma XH7SS7 Chromophobe carcinoma XH7AR7 Mucinous adenofibroma of borderline malignancy XH2J05 Liposarcoma, NOS XH9QC8 Lentiginous melanocytic naevus XH7SX5 Anal intraepithelial neoplasia, grade III XH6SC5 Hodgkin lymphoma, nodular sclerosis, NOS XH2Q13 Clear cell adenocarcinofibroma XH5544 Adenosarcoma XH2YZ1 Mucinous cystadenofibroma of borderline malignancy XH88L0 Simple lentigo XH62N8 Cervical intraepithelial neoplasia, grade III XH51K7 Hodgkin lymphoma, nodular sclerosis, cellular phase XH6YS0 Clear cell adenocarcinoma, mesonephroid XH1YV7 Carcinofibroma XH5NK4 Phyllodes tumour, borderline XH0RW4 Atypical lipomatous tumour XH9DB2 Acral naevus XH9ND8 Oesophageal squamous intraepithelial neoplasia (dysplasia), high grade XH62T3 Hodgkin lymphoma, nodular sclerosis, grade 1 XH4SQ4 Collecting duct carcinoma XH42V2 Carcinoma ex pleomorphic adenoma XH07C7 Serous adenofibroma of borderline malignancy XH4QB6 Lipofibromatosis XH8NP4 Meyerson naevus XH6F63 Vaginal intraepithelial neoplasia, grade III XH8K28 Hodgkin lymphoma, nodular sclerosis, grade 2 XH7QJ6 Combined hepatocellular carcinoma and cholangiocarcinoma XH2RK1 Carcinosarcoma, embryonal XH2M30 Serous cystadenofibroma of borderline malignancy XH0QR3 Angiomyolipoma, Epithelioid XH5YN0 Congenital melanocytic naevus, NOS XH5FT2 Vulvar intraepithelial neoplasia, grade III XH4KK0 Cyst-associated renal cell carcinoma XH2CV3 Endometrial stromal sarcoma, high grade XH9WF4 Spitz naevus, atypical XH2H04 Queyrat erythroplasia XH3FE9 Mature B-cell lymphomas XH0LH8 Enterochromaffin-like cell tumour XH1S94 Endometrial stromal sarcoma, low grade XH6RW7 Differentiated intraepithelial neoplasia – XH0QZ9 Lymphoplasmacytic lymphoma XH5P16 Fetal adenocarcinoma XH9HQ1 Gastrointestinal stromal tumour XH8A47 Angiomyofibroblastoma XH9MR8 Lymphangioma, NOS XH9KY6 Lentigo maligna – XH43K4 Immunocytoma XH7TE3 Follicular adenocarcinoma, moderately differentiated XH2WE3 Hepatoblastoma XH06N0 Benign fibrous histiocytoma XH6LF7 Capillary lymphangioma XH3XX3 Melanoma in situ XH3GS1 Basaloid squamous cell carcinoma – XH9TT4 Malignant lymphoma, plasmacytoid XH0VD1 Follicular adenocarcinoma, trabecular XH0765 Clear cell sarcoma of kidney XH3BQ8 Elastofibroma XH2EU7 Cavernous lymphangioma XH41F9 Precancerous melanosis, NOS XH0UU4 Papillary carcinoma, NOS – XH3KQ3 Plasmacytic lymphoma XH8FK7 Follicular adenocarcinoma, well differentiated XH64D5 Malignant chondroid syringoma XH2MW3 Fascial fibroma XH8G00 Cystic lymphangioma XH6S97 Papillary squamous cell carcinoma – XH1VV1 Mantle cell lymphoma XH3DN7 Follicular carcinoma, minimally invasive XH9M31 Malignant cystic nephroma XH5XQ3 Fibromyxoma XH2DS9 Lymphangiomyoma XH9L11 Acral melanoma XH7LH0 Squamous cell carcinoma, adenoid – XH1J80 Malignant lymphoma, mixed small and large cell, diffuse XH90N9 Follicular carcinoma, oxyphilic cell XH3RF3 Rhabdoid tumor, NOS XH3NQ0 Myofibroblastoma XH62A3 Haemolymphangioma XH3TK1 Amelanotic melanoma XH9DC1 Squamous cell carcinoma, clear cell type – XH2LN1 Primary effusion lymphoma XH3XT5 Glycogen-rich carcinoma XH0Y65 Mesodermal mixed tumour XH0953 Myofibroma XH8TE3 Balloon cell melanoma XH4CR9 Squamous cell carcinoma, keratinizing, NOS – XH8U09 Mediastinal large B-cell lymphoma XH4262 Goblet cell carcinoid XH7ZJ9 Mullerian mixed tumour XH7FV0 Periosteal fibroma XH10U6 Lymphangiosarcoma XH1P36 Desmoplastic melanoma, amelanotic XH84Q4 Squamous cell carcinoma, metastatic, NOS – XH9B17 Diffuse large B-cell lymphoma, NOS XH2EH4 Granular cell carcinoma XH27L5 Pancreatoblastoma XH8E66 Fibroma, NOS XH1Z15 Desmoplastic melanoma, NOS XH90Y3 Squamous cell carcinoma, microinvasive –– XH0RM6 Fibrin-associated EBV+ diffuse large B-cell lymphoma XH4T58 Hepatocellular carcinoma, clear cell type XH2FY9 Pleuropulmonary blastoma XH2ZF3 Desmoplastic fibroblastoma XH10K6 Lymphangiomyomatosis XH9NL4 Lentigo maligna melanoma XH0945 Squamous cell carcinoma, NOS – XH1VQ1 Malignant lymphoma, centroblastic, NOS XH9Q35 Hepatocellular carcinoma, fibrolamellar XH5VH1 Pulmonary blastoma XH7GT0 Gardner fibroma XH5L25 Malignant melanoma arising in giant congenital naevus XH2435 Squamous cell carcinoma, small cell, nonkeratinizing – XH9JY8 Malignant lymphoma, centroblastic, diffuse XH0G90 Hepatocellular carcinoma, pleomorphic type XH1TK5 Endometrial stromal sarcoma, NOS XH0XH6 Nuchal fibroma XH23B1 Malignant melanoma in junctional naevus XH6D80 Squamous cell carcinoma, spindle cell – XH78W3 Anaplastic large B-cell lymphoma XH5761 Hepatocellular carcinoma, scirrhous XH49Y5 Stromal sarcoma, NOS XH2WT6 Plexiform fibromyxoma XH5ZC7 Fibrous meningioma XH7L76 Malignant melanoma in precancerous melanosis XH5PM0 Verrucous carcinoma, NOS – XH9L43 B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma XH3T17 Hepatocellular carcinoma, spindle cell variant XH0V86 Mixed tumour, malignant, NOS XH0WB3 Fibroma of tendon sheath XH0R11 Lymphoplasmacyte-rich meningioma XH6XP3 Malignant melanoma, regressing XH7UR7 Warty carcinoma – XH3N15 Diffuse large B-cell lymphoma associated with chronic inflammation XH6YH5 Hurthle cell adenocarcinoma XH5QN3 Nephroblastoma, NOS XH8Q71 Solitary fibrous tumour/Haemangiopericytoma, grade 1 XH11P5 Meningioma, NOS XH1BP7 Meningeal melanomatosis XH6705 Squamous cell carcinoma, large cell, nonkeratinizing, NOS – XH1QK0 EBV positive diffuse large B-cell lymphoma XH8MQ3 Hurthle cell carcinoma XH0H07 Hepatoblastoma, epithelioid XH7TH6 Calcifying fibrous tumour XH40T5 Meningothelial meningioma XH5QP3 Mucosal lentiginous melanoma XH2JN3 Squamous cell carcinoma with horn formation – XH8657 Primary cutaneous DLBCL, leg type XH8WM4 Linitis plastica XH33R5 Hepatoblastoma, mixed epithelial-mesenchymal XH5LM1 Nodular fasciitis XH7N06 Metaplastic meningioma XH5F94 Neurotropic melanoma, malignant XH1E40 Lymphoepithelial carcinoma – XH2MP0 Primary diffuse large B-cell lymphoma of CNS XH6TK0 Lipid-rich carcinoma XH2W45 Carcinosarcoma, NOS XH1UJ5 Histiocytoma, NOS XH1F70 Microcystic meningioma XH4QG5 Nodular melanoma XH4GV2 Schmincke tumour – XH2WM7 High grade B-cell lymphoma, NOS XH81N8 Merkel cell carcinoma XH7TL5 Adenomyoepithelioma with carcinoma XH8B90 Dermatofibroma, NOS XH6Z51 Secretory meningioma XH08X7 Superficial spreading melanoma XH0Z16 Pseudovascular squamous cell carcinoma – XH23Z3 High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements XH7019 Mixed acidophil-basophil carcinoma XH3B27 Phosphaturic mesenchymal tumour, malignant XH7436 Sclerosing pneumocytoma XH3L73 Haemangioblastic meningioma XH4846 Malignant melanoma, NOS XH24M0 Papillary-basaloid carcinoma – XH86B5 Vitreoretinal lymphoma XH8EZ3 Mixed acinar-endocrine carcinoma XH43E6 Myoepithelial carcinoma XH5DP4 Deep histiocytoma XH4ZM7 Psammomatous meningioma XH25M1 Spindle cell melanoma, NOS XH0EJ7 Squamous cell carcinoma, HPV positive – XH7Z25 Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS XH74Y9 Mixed acinar-endocrine-ductal carcinoma XH9N95 Mesenchymoma, malignant XH9VG1 Juvenile histiocytoma XH6L68 Angiomatous meningioma XH8HA2 Mixed epithelioid and spindle cell melanoma XH2137 Squamous cell carcinoma, HPV negative – XH4KA9 Burkitt lymphoma, NOS XH6H10 Mixed adenoneuroendocrine carcinoma XH42Q2 Embryonal sarcoma XH33Q1 Reticulohistiocytoma XH4EX5 Transitional meningioma XH0QL5 Epithelioid cell melanoma XH6FU0 Warty-basaloid carcinoma – XH0H23 Burkitt-like lymphoma XH2AM6 Mixed cell adenocarcinoma XH4VQ1 Gastroblastoma XH8ZE3 Calcifying aponeurotic fibroma XH5KW3 Spindle cell melanoma, type A XH9XR8 Keratoacanthoma – XH8NN2 Burkitt-like lymphoma with 11q aberration XH7CY5 Mixed ductal-endocrine carcinoma XH5CT2 Gastrointestinal autonomic nerve tumour XH2874 Collagenous fibroma XH0324 Meningioma, malignant XH5YE7 Spindle cell melanoma, type B –– XH6B12 Burkitt cell leukaemia XH6UP4 Mixed endocrine and exocrine adenocarcinoma XH0712 Gastrointestinal pacemaker cell tumour XH3665 Plaque-like CD34 positive dermal fibroma XH2NY9 Papillary meningioma XH1G74 Blue naevus, malignant – XH0WP6 T-cell/histiocyte rich large B-cell lymphoma XH7DG7 Mixed medullary-follicular carcinoma XH8173 Acral fibromyxoma XH6QS9 Rhabdoid meningioma XH7JW1 Low cumulative sun damage melanoma XH2AW8 Synovioma, benign – XH0MV1 Splenic marginal zone B-cell lymphoma XH3340 Mixed medullary-papillary carcinoma XH1JB4 Cystic partially differentiated nephroblastoma XH5JG7 Sclerotic fibroma XH5976 Meningeal sarcomatosis XH8DS3 Malignant Spitz tumour – XH0LK1 Follicular lymphoma, NOS XH9LZ7 Mixed pancreatic endocrine and exocrine tumour, malignant XH10F1 Mesoblastic nephroma XH6JX7 Proliferative fasciitis XH3DN1 Melanoma, meningeal XH9B22 Synovial sarcoma, NOS – XH9RH9 Follicular lymphoma, pediatric type XH1108 Nonencapsulated sclerosing carcinoma XH0G00 Sialoblastoma XH87F9 Proliferative myositis XH71V9 Clear cell meningioma XH8681 Nevoid melanoma XH77N6 Clear cell sarcoma, NOS – XH79L3 Follicular lymphoma, grade 2 XH09D6 Oxyphilic adenocarcinoma XH6R49 Stromal tumour, NOS XH15M9 Epithelioid fibrous histiocytoma XH2LS4 Chordoid meningioma XH9346 Synovial sarcoma, spindle cell – XH6Y69 Follicular lymphoma, grade 1 XH3614 Islet cell adenocarcinoma XH4N88 Metanephric stromal tumour XH1BV2 Pleomorphic fibroma XH1PF6 Atypical meningioma XH2C28 Giant pigmented naevus, NOS XH06L8 Synovial sarcoma, epithelioid cell – XH9L76 Follicular lymphoma, duodenal type XH3709 Pancreatic neuroendocrine tumor, nonfunctioning XH8747 Stromal tumour of uncertain malignant potential XH18K3 Dermatomyofibroma XH1XJ3 Intermediate and giant congenital naevus XH1J28 Synovial sarcoma, biphasic – XH6RN1 Follicular lymphoma, grade 3 XH6XY9 Pancreatobiliary-type carcinoma XH8X78 Calcifying nested stromal-epithelial tumor XH2HE9 Myopericytoma XH2RY7 Meningeal melanocytoma XH3797 Biphenotypic sinonasal sarcoma – XH6SU8 Large B-cell lymphoma with IRF4 rearrangement XH1ND9 Papillary carcinoma of thyroid XH2AD1 Mesenchymoma, NOS XH5FY2 Fibrous dysplasia XH3SX7 Adenoma of rete ovarii XH6AH3 Proliferative dermal lesion in congenital naevus XH5854 Malignant melanoma of soft parts – XH1X21 Marginal zone B-cell lymphoma, NOS XH85E5 Papillary carcinoma, columnar cell XH5LL8 Primitive non-neural granular cell tumor XH5AH3 Mesonephroma, benign XH4VD0 Pigmented epithelioid melanocytoma – XH1V99 Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue XH0426 Papillary carcinoma, diffuse sclerosing XH8EV4 Fascial fibrosarcoma – XH6JB5 Primary choroidal lymphoma XH0Q59 Papillary carcinoma, encapsulated, of thyroid XH6LT0 Fibromyxosarcoma XH71B5 Adenocarcinoma of rete ovarii XH9QW0 Microscopic thymoma – XH8EM2 In situ mantle cell neoplasia XH29M4 Papillary carcinoma, follicular variant XH6ZU1 Clear cell cystadenoma XH7BC6 Infantile fibrosarcoma XH5WG5 Mesonephroma, malignant XH2SD0 Adenomatoid odontogenic tumour XH4341 Thymoma, benign – XH3SG2 EBV positive mucocutaneous ulcer XH5YT2 Papillary carcinoma, oncocytic variant XH55F1 Cystic tumour of atrio-ventricular node XH3406 Periosteal fibrosarcoma XH44W7 Ameloblastic fibro-odontoma XH0707 Ectopic hamartomatous thymoma – XH4L38 In situ follicular neoplasia XH2AW7 Papillary microcarcinoma XH5232 Intraductal papillary-mucinous adenoma XH56W2 Periosteal sarcoma, NOS XH2WJ5 Wolffian tumour XH0964 Ameloblastic fibrodentinoma XH3400 Mature T- and NK-cell lymphomas XH1D07 Papillary renal cell carcinoma XH4070 Intraductal papillary-mucinous tumour with intermediate dysplasia XH1HP3 Solitary fibrous tumour, malignant XH3R33 Calcifying odontogenic cyst XH6WN9 Thymoma, type A – XH8R56 Mycosis fungoides XH4Q20 Papillotubular adenocarcinoma XH8MD2 Intraductal papillary-mucinous tumour with low grade dysplasia XH4EP1 Fibrosarcoma, NOS XH5Y46 Cementifying fibroma XH0JH0 Thymoma, type AB – XH0EH1 Granulomatous slack skin XH1JZ0 Parietal cell carcinoma XH8ML6 Intraductal papillary-mucinous tumour with moderate dysplasia XH1DA3 Solitary fibrous tumour/Haemangiopericytoma, grade 3 XH2VV6 Fibrous mesothelioma, benign XH52T0 Cemento-ossifying fibroma XH66U8 Thymoma, type B1 – XH8HN3 Sezary syndrome XH6153 Renal cell carcinoma, chromophobe type XH0556 Serous microcystic adenoma XH2668 Myofibroblastic sarcoma XH1SS1 Mesothelioma, benign XH4VL1 Cementoblastoma, benign XH2G89 Thymoma, type B2 – XH3HJ2 Mature T-cell lymphoma, NOS XH9DH7 Renal cell carcinoma, sarcomatoid XH38C4 Serous surface papilloma XH0947 Malignant fibrous histiocytoma XH0KC4 Epithelioid mesothelioma, benign XH1MT3 Odontogenic fibroma, NOS XH4EW9 Thymoma, type B3 – XH92G2 Lymphoepithelioid lymphoma XH4FS4 Scirrhous adenocarcinoma XH5RJ2 Cystadenoma, NOS XH8WH0 Myxofibrosarcoma XH67N8 Well differentiated papillary mesothelioma XH7H47 Complex odontoma XH3734 Thymoma, NOS – XH14S3 Follicular T-cell lymphoma XH34G3 Solid carcinoma with mucin formation XH8TJ0 Serous cystadenoma, NOS XH9V92 Dermatofibrosarcoma protuberans, fibrosarcomatous XH8U12 Peritoneal inclusion cysts XH57B1 Compound odontoma XH1GA4 Intrapulmonary thymoma – XH6SR1 Nodal peripheral T-cell lymphoma with T follicular helper phenotype XH0JE3 Superficial spreading adenocarcinoma XH0FM6 Papillary cystadenoma, NOS XH6BY3 Adenomatoid tumour, NOS XH6W94 Gigantiform cementoma XH6QN6 Sclerosing thymoma – XH1J86 Angioimmunoblastic T-cell lymphoma XH7EX3 Trabecular adenocarcinoma XH6H73 Mucinous cystadenoma, NOS XH6116 Abdominal fibromatosis XH06N8 Odontoameloblastoma XH3DX0 Metaplastic thymoma – XH3NV1 Subcutaneous panniculitis-like T-cell lymphoma XH4TA4 Tubular adenocarcinoma XH8XL1 Mucinous cystic neoplasm with intermediate-grade dysplasia XH13Z3 Aggressive fibromatosis XH54S8 Fibrous mesothelioma, malignant XH12N4 Dentinogenic ghost cell tumour XH6AK2 Thymic carcinoma, NOS – XH1951 Cutaneous T-cell lymphoma, NOS XH1Z69 Typical carcinoid XH6NK7 Mucinous cystic neoplasm with low-grade intraepithelial neoplasia XH1RM7 Atypical fibrous histiocytoma XH0XV0 Mesothelioma, malignant XH48L4 Odontogenic myxoma XH6ZG8 Spindle epithelial tumour with thymus-like element – XH2513 Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma XH22Z8 Carcinoma of Skene, Cowper and Littre Glands XH7K36 Mucinous cystic tumour with intermediate dysplasia XH9HH5 Cellular fibroma XH1DX8 Mesothelioma, biphasic, malignant XH43L1 Odontogenic tumour, benign XH33N4 Intrathyroid thymic carcinoma – XH7S84 Primary cutaneous acral CD8 positive T-cell lymphoma XH0X20 Villous adenocarcinoma XH7834 Mucinous cystic tumour with moderate dysplasia XH5MH2 Congenital generalised fibromatosis XH0VP5 Epithelioid mesothelioma, malignant XH4PV9 Squamous odontogenic tumour – XH7EZ9 Anaplastic large cell lymphoma, T cell and Null cell type XH96Q1 Acinar cell adenoma XH0A57 Water-clear cell adenocarcinoma XH0EK3 Mucinous cystic neoplasm with low-grade dysplasia XH85R1 Myofibroblastic tumour, peribronchial XH8FX0 Cementoma, NOS XH56K5 Micronodular thymoma with lymphoid stroma – XH1LC0 Anaplastic large cell lymphoma, NOS XH8UE4 Adenocarcinoma, metastatic, NOS XH8EW6 Mucinous cystic neoplasm with intermediate-grade intraepithelial neoplasia XH1N00 Myofibromatosis XH85T6 Well differentiated papillary mesothelioma of the pleura XH4QJ8 Odontoma, NOS – XH9484 Anaplastic large cell lymphoma, ALK positive XH3PG9 Acinar cell carcinoma XH4ZC3 Basal cell carcinoma of the prostate XH9BE7 Seromucinous cystadenoma XH2D15 Myxoinflammatory fibroblastic sarcoma XH1SV4 Ameloblastoma, NOS – XH8D49 Hepatosplenic T-cell lymphoma XH99S4 Acinar cell cystadenocarcinoma XH4W48 Hepatocellular carcinoma, NOS XH2M29 Mucinous adenoma XH0TA8 Atypical myxoinflammatory fibroblastic tumour XH2M31 Peripheral odontogenic fibroma XH0TP8 Sinonasal papilloma, exophytic – XH9FT0 Intestinal T-cell lymphoma XH9B93 Mixed acinar-ductal carcinoma XH81Q9 Bronchial adenoma, cylindroid XH5RX2 Mucous gland adenoma XH9526 Haemosiderotic fibrolipomatous tumour XH6M86 Ossifying fibroma XH06Y3 Ameloblastic fibroma XH3HQ8 Transitional papilloma, inverted, NOS – XH1AG7 Monomorphic epitheliotropic intestinal T-cell lymphoma XH0F68 Acinar adenocarcinoma of the lung XH92Y9 Thymic carcinoma with adenoid cystic carcinoma-like features XH9MS1 Papillary cystadenofibroma XH75J5 Palmar/plantar type fibromatosis XH23E0 Aneurysmal bone cyst XH4PT4 Calcifying epithelial odontogenic tumour XH5A08 Urothelial papilloma, inverted – XH5SC3 Primary cutaneous anaplastic large cell lymphoma XH1YZ3 Cribriform carcinoma, NOS XH7E62 Solitary fibrous tumour, NOS XH39C5 Sinonasal ameloblastoma XH5M82 Urothelial papilloma, NOS – XH0353 Primary mucosal CD30+ T-cell lymphoproliferative disorder XH2SK9 Acinar cell tumour XH4YG1 Cribriform comedo-type carcinoma XH5E08 Intraductal papillary-mucinous carcinoma, non-invasive XH1EH1 Solitary fibrous tumour/Haemangiopericytoma, grade 2 XH8F52 Adamantinoma of long bones XH5ZZ6 Ameloblastoma, unicystic type – XH5LU6 NK/T-cell lymphoma, nasal and nasal-type XH74B2 Serrated adenocarcinoma XH3MB3 Intraductal papillary mucinous neoplasm with high grade dysplasia XH66Z0 Myofibroblastic tumour, NOS XH4KQ4 Ameloblastoma, extraosseous/peripheral type XH12F0 Papillary urothelial carcinoma, non-invasive – XH0B02 Indolent T-cell lymphoproliferative disorder of gastrointestinal tract XH06M2 Mucinous cystadenocarcinoma, non-invasive XH6YK5 Desmoplastic fibroma XH5GH8 Urothelial carcinoma in situ – XH3QE7 Primary cutaneous CD4 positive small/medium T-cell lymphoproliferative disorder XH9574 Acidophil adenoma XH6770 Apudoma XH81P3 Mucinous cystic neoplasm with high-grade dysplasia XH4QZ8 Dermatofibrosarcoma protuberans, NOS XH6C72 Melanotic neuroectodermal tumour XH1MW0 Ameloblastic odontosarcoma – XH7EL2 Primary cutaneous CD4-positive small/medium T-cell lymphoma XH3DV3 Adenoma, NOS XH6VL9 Atypical adenoma XH8PZ6 Serous intraepithelial carcinoma XH5CT4 Pigmented dermatofibrosarcoma protuberans XH7MT7 Benign notochordal cell tumour XH96J9 Ameloblastoma, metastasizing XH4UA2 Cylindrical cell carcinoma – XH50S7 Intravascular large B-cell lymphoma XH1CV4 Adenomatous polyposis coli XH3T38 Atypical follicular adenoma XH9DM1 Serous borderline tumour, micropapillary variant XH9AV8 Giant cell fibroblastoma XH0S20 Parachordoma XH4M89 Odontogenic tumour, malignant XH35M0 Schneiderian carcinoma – XH9T74 Anaplastic large cell lymphoma, ALK negative XH1YP0 Adrenal cortical adenoma, clear cell XH0S86 Clear cell adenofibroma of borderline malignancy XH8NV8 Serous tubal intraepithelial carcinoma (STIC) XH4GL1 Plexiform fibrohistiocytic tumour XH0XD5 Ameloblastic fibrosarcoma XH8EH1 Transitional cell carcinoma, NOS – XH05D8 Breast implant-associated anaplastic large cell lymphoma XH2CT2 Adrenal cortical adenoma, compact cell XH5DQ2 Endometrioid adenoma, borderline malignancy XH1YW4 Serous endometrial intraepithelial carcinoma XH9362 Angiomatoid fibrous histiocytoma XH2S71 Mixed pineal tumour XH4LP1 Odontogenic carcinosarcoma XH7TL4 Transitional carcinoma – XH40C0 Primary cutaneous CD30+ T-cell lymphoproliferative disorder XH60N5 Adrenal cortical adenoma, glomerulosa cell XH76W6 Multiple endocrine adenomas XH7050 Haemangiopericytic meningioma XH1S48 Pineal parenchymal tumour of intermediate differentiation XH2BX2 Ghost cell odontogenic carcinoma XH5P27 Urothelial carcinoma, sarcomatoid XH2216 Precursor cell lymphoblastic lymphoma XH2VZ8 Adrenal cortical adenoma, mixed cell XH8468 Pulmonary adenomatosis XH5WU3 Intraductal papillary-mucinous carcinoma, invasive XH1ZH1 Pineoblastoma XH5DZ4 Clear cell odontogenic carcinoma XH0NZ4 Papillary urothelial carcinoma – XH6TZ4 Systemic EBV positive T-cell lymphoproliferative disease of childhood XH2FJ6 Adrenal cortical adenoma, pigmented XH54H3 Hypernephroid tumour XH2SE1 Intraductal papillary mucinous neoplasm with an associated invasive carcinoma XH3D20 Transitional pineal tumour XH08S6 Transitional cell carcinoma, micropapillary – XH84A5 Primary cutaneous gamma/delta T-cell lymphoma XH9356 Alveolar adenoma XH7PR9 Multilocular cystic renal neoplasm of low malignant potential XH0572 Micropapillary serous carcinoma XH3GV5 Teratoma, benign XH7K24 Neuroectodermal tumour, NOS XH1P03 Odontogenic tumour, NOS XH3UJ1 Cloacogenic carcinoma – XH14N1 Precursor cell lymphoblastic lymphoma, NOS XH60D1 Basal cell adenoma XH9DS4 Endometrioid adenofibroma, borderline malignancy XH5P21 Solid pseudopapillary carcinoma XH9F67 Dermoid cyst, NOS XH6P76 Peripheral primitive neuroectodermal tumour XH2V80 Basaloid carcinoma – XH42X4 Blastic NK-cell lymphoma XH3AH8 Basophil adenoma XH4JG0 Tubular carcinoid XH0219 Cystadenocarcinoma, NOS XH52Q4 Teratoma, prepubertal type XH9GH0 Chordoma, NOS XH4W76 Urothelial carcinoma, micropapillary – XH1DB1 Blastic plasmacytoid dendritic cell neoplasm XH6KR6 Bile duct adenoma XH4XL2 Aggressive papillary tumour XH7A08 Serous carcinoma, NOS XH22M4 Struma ovarii, NOS XH8KJ8 Ewing sarcoma XH9SY5 Enchondroma – XH0AK5 Hydroa vacciniforme-like lymphoproliferative disorder XH0778 Bile duct cystadenoma XH9PN4 Well differentiated tumor of uncertain malignant potential XH6JU6 Papillary cystadenocarcinoma, NOS XH0FH0 Askin tumour XH5Y87 Osteochondroma XH7R01 Cylindrical cell papilloma XH7BS0 Biliary intraepithelial neoplasia, low grade XH6SY0 Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) XH12V5 Low grade serous carcinoma XH8AD3 Intratubular malignant germ cells XH17D8 Chondroid chordoma XH4818 Osteoma, NOS XH4PB5 Schneiderian papilloma, inverted XH5YG5 Biliary papillomatosis XH1Y66 Hyalinizing trabecular tumour XH24N6 High grade serous carcinoma XH7303 Dedifferentiated chordoma XH61J9 Osteoid osteoma, NOS XH5UU5 Papillary urothelial neoplasm of low malignant potential XH4KF3 Immunoproliferative disease, NOS XH1TD7 Canalicular adenoma XH27W5 Follicular tumor of uncertain malignant potential XH1390 Mucinous cystadenocarcinoma, NOS XH24E0 Dysgerminoma XH4316 Osteoblastoma, NOS XH8FH7 Sinonasal papilloma, inverted XH8GW4 Waldenstrom macroglobulinemia XH6WK1 Chief cell adenoma XH9T60 Clear cell papillary renal cell carcinoma XH1K19 Mucinous cystic tumour with an associated invasive carcinoma XH0A34 Germ cell tumour, nonseminomatous XH1AZ2 Craniopharyngioma XH6KR3 Osteochondromyxoma XH8CD4 Sinonasal papilloma, oncocytic XH7RJ1 Heavy chain disease, NOS XH7475 Chromophobe adenoma XH6CZ3 Clear cell borderline tumour XH4186 Seromucinous carcinoma XH1E13 Germinoma XH15X9 Craniopharyngioma, adamantinomatous XH23J5 Bizarre parosteal osteochondromatous proliferation XH1Y65 Alpha heavy chain disease XH9JJ4 Clear cell adenofibroma XH1S75 Mucinous adenocarcinoma XH7SG5 Hepatoid yolk sac tumour XH2BF0 Craniopharyngioma, papillary XH0NS4 Chondroma, NOS XH1EA7 Gamma heavy chain disease XH8R87 Clear cell adenoma XH4U83 Pseudomyxoma peritonei with unknown primary site XH0N49 Immature teratoma, malignant XH8QA9 Pinealoma XH49G1 Juxtacortical chondroma XH8CX2 Hydatidiform mole, NOS XH2JK2 Mu heavy chain disease XH6J91 Cylindroma of skin XH6YZ9 Apocrine adenoma XH5EQ2 Mucinous tubular and spindle cell carcinoma XH2PP9 Malignant teratoma, undifferentiated XH1K94 Pineocytoma XH3BC3 Periosteal chondroma XH5325 Partial hydatidiform mole XH3SS7 Immunoproliferative small intestinal disease XH5GN1 Eccrine dermal cylindroma XH0AQ8 Clear cell hidradenoma XH83J5 Pseudomyxoma peritonei XH9Z28 Polyembryoma XH89S0 Chondromyxoid fibroma XH71D5 Lymphomatoid granulomatosis, grade 3 XH6685 Embryonal adenoma XH46Z2 Eccrine acrospiroma XH4KC5 Mucinous carcinoma, gastric type XH6YQ4 Seminoma, anaplastic XH1XL9 Subungual exostosis XH3WM1 Choriocarcinoma combined with other germ cell elements XH3K13 Oesophageal glandular dysplasia (intraepithelial neoplasia), low grade XH42Z3 Eccrine papillary adenoma XH56K0 Metastatic signet ring cell carcinoma XH80D1 Spermatocytic seminoma XH1J36 Mucoepidermoid carcinoma XH0774 Malignant teratoma, trophoblastic XH1NV1 Monoclonal gammopathy of undetermined significance XH83X4 Flat adenoma XH25Z9 Eccrine poroma XH5AF5 Mucin-producing adenocarcinoma XH56W1 Teratocarcinoma XH1Y90 Central osteosarcoma XH8PK7 Choriocarcinoma, NOS XH3U73 Angiocentric immunoproliferative lesion XH0LM0 Follicular adenoma XH3AM1 Spiradenoma, NOS XH4546 Signet ring cell carcinoma XH09W7 Yolk sac tumour XH80V3 Mucoepidermoid tumour XH3T03 Chondroblastic osteosarcoma XH8FW3 Trophoblastic tumour, epithelioid XH4P09 Lymphomatoid granulomatosis XH5SM2 Follicular adenoma, oxyphilic cell XH4YU8 Follicular fibroma XH2KK0 Poorly cohesive carcinoma XH9FM4 Seminoma, NOS XH23T4 Fibroblastic osteosarcoma XH2A53 Angioimmunoblastic lymphadenopathy (AIL) XH6AF9 Glandular intraepithelial neoplasia, low grade XH7NR3 Hidrocystoma XH3RD4 Krukenberg tumour XH8MB9 Embryonal carcinoma, NOS XH29N8 Fibrochondrosarcoma XH46G2 Invasive hydatidiform mole XH0HS7 T-gamma lymphoproliferative disease XH3BK2 Glandular papilloma XH4MV7 Hidradenoma, NOS XH0XE5 Signet ring cell/histiocytoid carcinoma XH15X1 Yolk sac tumour, post pubertal type XH7CL0 Angiomyoma XH6TL0 High grade surface osteosarcoma XH1RM5 Placental site trophoblastic tumour XH2WA6 Immunoglobulin deposition disease XH6PG8 Hurthle cell adenoma XH4DX4 Papillary hidradenoma XH3AE9 Solid pseudopapillary neoplasm of pancreas XH7YZ9 Teratoma, malignant, NOS XH9824 Bizarre leiomyoma XH9LS2 Intracortical osteosarcoma XH4F97 Lymphomatoid granulomatosis, grade 1 XH5X53 Hurthle cell tumour XH1PY0 Syringocystadenoma papilliferum XH43T4 Malignant teratoma, intermediate XH9662 Cellular leiomyoma XH9119 Intraosseous well differentiated osteosarcoma XH7BG6 Lymphomatoid granulomatosis, grade 2 XH6M13 Juxtaglomerular tumour XH96Q5 Skin appendage adenoma XH2FF0 Mucinous cystic tumour of borderline malignancy XH33E8 Teratoma with malignant transformation XH8S79 Epithelioid leiomyoma XH06W9 Osteosarcoma in Paget disease of bone XH2N45 Myelodysplastic syndrome with single lineage dysplasia XH16T1 IgM monoclonal gammopathy of undetermined significance XH0W31 Lactating adenoma XH3U61 Sweat gland adenoma XH1P30 Papillary cystadenoma, borderline malignancy XH2PS1 Mixed germ cell tumour XH4729 Fetal rhabdomyoma XH8HG5 Parosteal osteosarcoma XH5B21 Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia XH8P28 Lipoadenoma XH06Y5 Syringofibroadenoma XH0RB9 Seromucinous borderline tumour XH9QP9 Germ cell tumour with associated haematological malignancy XH4FS5 Lipoleiomyoma XH48A9 Periosteal osteosarcoma XH79X8 Myelodysplastic syndrome with excess blasts XH4BL1 Plasmacytoma, NOS XH68V1 Liver cell adenoma XH6325 Syringoma, NOS XH3ZK9 Serous borderline tumour, NOS XH5U02 Mixed teratoma and seminoma XH1CZ1 Myoma XH4EZ4 Small cell osteosarcoma XH1D20 Refractory anaemia with excess blasts in transformation XH4XA9 Plasma cell myeloma XH19E3 Macrofollicular adenoma XH9GB7 Syringomatous tumour of nipple XH3FD4 Solid pseudopapillary tumor of ovary XH5PU7 Struma ovarii, malignant XH4EP9 Plexiform leiomyoma XH5CL5 Telangiectatic osteosarcoma XH5DA2 Myelodysplastic syndrome with multilineage dysplasia XH7GC9 Plasma cell leukaemia XH0JC7 Metanephric adenoma XH1NC5 Sebaceous adenoma XH7BB4 Low grade appendiceal mucinous neoplasm XH1P78 Teratocarcinosarcoma XH4CY6 Leiomyoma, NOS XH1XF3 Osteosarcoma, NOS XH3T02 Myelodysplastic syndrome with isolated del (5q) XH0N40 Plasmacytoma, extramedullary XH3DH3 Microcystic adenoma XH0SH5 Sebaceous epithelioma XH9CC7 Myxoid leiomyoma XH2CD6 Osteosarcoma, extraskeletal XH0L58 Therapy-related myelodysplastic syndrome, NOS XH6YR5 Plasmablastic lymphoma XH5LD9 Mixed acidophil-basophil adenoma XH7AL8 Ceruminous adenoma XH0K61 Gonadoblastoma XH8WG9 Rhabdomyoma, NOS XH7N84 Low grade central osteosarcoma XH7PK9 Myelodysplastic syndrome, NOS XH1EB9 ALK positive large B-cell lymphoma XH0WV8 Mixed adenomatous and hyperplastic polyp XH8R55 Spindle cell predominant trichodiscoma XH6RX1 Intracystic papillary neoplasm with low grade intraepithelial neoplasia XH83G5 Teratoma, NOS XH4BG5 Adult cellular rhabdomyoma XH8J23 Chondrosarcoma, NOS XH8BA8 Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia XH5HJ5 Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease XH1XU4 Mixed cell adenoma XH1A80 Apocrine poroma XH5ZH7 Intraductal papillary neoplasm with low grade intraepithelial neoplasia XH4NU1 Germ cell tumour, regressed XH2736 Glycogenic rhabdomyoma XH6LT5 Chondrosarcoma, grade 2 XH2CQ8 Monomorphic adenoma XH8N28 Poroma, NOS XH4LZ4 Intraductal papilloma XH5MG2 Immature teratoma of the lung XH5AF2 Genital rhabdomyoma XH0Y34 Chondrosarcoma, grade 3 XH6CZ4 Multiple adenomatous polyps XH0QL4 Sebaceoma XH7QS7 Intraductal tubular-papillary neoplasm, low grade XH2KP9 Immature teratoma of the thymus XH8B88 Leiomyoma, apoplectic XH5FH4 Juxtacortical chondrosarcoma XH3EJ1 Myeloproliferative neoplasm, unclassifiable XH6A72 Mast cell sarcoma XH9Z86 Oxyphilic adenoma XH6HK2 Intraductal papillary neoplasm, NOS XH2XW3 Strumal carcinoid XH5Z76 Leiomyoma, hydropic XH1S32 Periosteal chondrosarcoma XH28M3 Myelodysplastic/myeloproliferative neoplasm, unclassifiable XH2992 Malignant mastocytosis XH0BF2 Pancreatobiliary neoplasm, non-invasive XH7WE6 Porocarcinoma in situ XH60S7 Intraductal papilloma with atypical ductal hyperplasia XH5PC3 Immature teratoma of thyroid XH5G84 Cotyledonoid leiomyoma XH6W00 Chondroblastoma, malignant XH10N1 Aggressive systemic mastocytosis XH6GG6 Pancreatic microadenoma XH7GN3 Adenoma of nipple XH6GV7 Myolipoma XH9344 Myxoid chondrosarcoma XH2LK2 Lymphoproliferative disorder, NOS XH1H01 Systemic mastocytosis with AHNMD XH1BH4 Papillomatosis, glandular XH9L77 Apocrine adenocarcinoma XH9F80 Intracystic papillary adenoma XH8X47 Mesenchymal chondrosarcoma XH2R75 Post transplant lymphoproliferative disorder, NOS XH5191 Systemic mastocytosis with associated haematological clonal non-mast cell disorder XH6EJ4 Papillotubular adenoma XH6FB5 Digital papillary adenocarcinoma XH4JD3 Intraductal papillomatosis, NOS XH6911 Tenosynovial giant cell tumour, localised XH27W3 Angiomyosarcoma XH7XB9 Clear cell chondrosarcoma XH74K1 Polymorphic post transplant lymphoproliferative disorder XH5ER6 Mast cell leukaemia XH1QS0 Lactotroph adenoma XH7VK4 Porocarcinoma, NOS XH0HZ1 Tenosynovial giant cell tumour, NOS XH13Z5 Epithelioid leiomyosarcoma XH6E77 Dedifferentiated chondrosarcoma XH1VJ3 Erdheim-Chester disease XH5903 Serrated adenoma XH58E1 Malignant eccrine spiradenoma XH8P86 Comedocarcinoma, noninfiltrating XH7ED4 Leiomyosarcoma, NOS XH9G87 Trabecular adenoma XH7NK9 Hidradenocarcinoma XH6AH7 Intraductal papillary neoplasm with high grade intraepithelial neoplasia XH0492 Giant cell tumour of bone, malignant XH08B3 Mixed embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma XH2RD1 Aggressive osteoblastoma XH0453 Polycythaemia vera XH1J17 Mastocytoma, NOS XH8T50 Turban tumour XH17P2 Microcystic adnexal carcinoma XH9VG0 Noninfiltrating intraductal papillary adenocarcinoma XH84X1 Malignant giant cell tumour of soft parts XH6YL0 Mixed type rhabdomyosarcoma XH70W8 Osteochondromatosis, NOS XH5HH7 Myeloproliferative neoplasm, NOS XH74F2 Cutaneous mastocytosis XH0731 Villous papilloma XH89V4 Adnexal adenocarcinoma, NOS XH1H31 Intraductal carcinoma, noninfiltrating, NOS XH8H07 Myosarcoma XH5BT0 Chondromatosis, NOS XH7GG7 Primary myelofibrosis XH2RG8 Diffuse cutaneous mastocytosis XH8UC1 Water-clear cell adenoma XH5LY3 Sweat gland adenocarcinoma XH4V32 Ductal carcinoma in situ, NOS XH4TC2 Giant cell tumour of bone, NOS XH3122 Myxoid leiomyosarcoma XH0FY0 Atypical cartilaginous tumour XH4ZM5 Essential thrombocythemia XH8VS0 Urticaria pigmentosa XH28X1 Cylindroma of breast XH4VR2 Sebaceous carcinoma XH11S9 Intraductal papilloma with DCIS XH81M1 Giant cell tumour of soft parts, NOS XH5SX9 Pleomorphic rhabdomyosarcoma, NOS XH4NK2 Chondroblastoma, NOS XH5NQ7 Chronic neutrophilic leukaemia XH2Y59 Indolent systemic mastocytosis XH8MU5 Adenomatous polyp, NOS XH8NE4 Eccrine adenocarcinoma XH64S7 Intraductal tubular-papillary neoplasm, high grade XH52J9 Tenosynovial giant cell tumour, diffuse XH4VB5 Pleomorphic rhabdomyosarcoma, adult type XH51D2 Chronic eosinophilic leukaemia XH2RL8 Solitary mastocytoma of skin XH7SY6 Tubular adenoma, NOS XH6Z69 Ceruminous adenocarcinoma XH9XV2 Noninfiltrating intracystic carcinoma XH5AQ9 Malignant tenosynovial giant cell tumour XH0GA1 Rhabdomyosarcoma, NOS XH07H5 Myeloid and lymphoid neoplasms with PDGFRA rearrangement XH2F06 Sessile serrated adenoma XH9C82 Malignant neoplasm arising from pre-existing spiradenoma XH0134 Solid papillary carcinoma in situ XH83G1 Embryonal rhabdomyosarcoma, NOS XH2012 Gangliocytic paraganglioma XH6QD4 Myeloid neoplasms with PDGFRB rearrangement XH63V9 Sessile serrated polyp XH2ZK9 Malignant neoplasm arising from pre-existing cylindroma XH39X8 Intraductal carcinoma, clinging, high grade XH4749 Embryonal rhabdomyosarcoma, pleomorphic XH47J2 Glomus tumour, NOS XH1WR8 Myeloid and lymphoid neoplasms with FGFR1 abnormalities XH2WJ3 Malignant histiocytosis XH9PD9 Traditional sessile serrated adenoma XH9NW9 Malignant neoplasm arising from pre-existing spiradenocylindroma XH9SL6 Cystic hypersecretory carcinoma, intraductal XH0RF9 Choroid plexus papilloma, NOS XH7V57 Sarcoma botryoides XH4CC6 Perivascular epithelioid tumour, benign XH2WB4 Myeloid or lymphoid neoplasm with PCM1-JAK2 XH7PV7 Histiocytic medullary reticulosis XH5QL3 Atypical adenomatous hyperplasia XH65F9 Sialadenoma papilliferum XH0GQ3 Intraductal micropapillary carcinoma XH0H76 Dysembryoplastic neuroepithelial tumour XH7NM2 Spindle cell rhabdomyosarcoma XH3RX1 Glomangioma XH4XT4 Acute progressive histiocytosis X XH09B0 Papillary adenoma, NOS XH0BE5 Syringocystadenocarcinoma papilliferum XH2HB2 Lobular carcinoma in situ, pleomorphic XH1Q28 Sellar ependymoma XH7099 Alveolar rhabdomyosarcoma XH2702 Glomangiomyoma XH8VV4 Histiocytosis X, NOS XH90D6 Villous adenoma, NOS XH6EH0 Lobular carcinoma in situ, NOS XH0S12 Ectomesenchymoma XH4S92 Leukaemia, NOS XH86U0 Hand-Schuller-Christian disease XH10B0 Tubulovillous adenoma, NOS XH8BW1 Sweat gland tumour, NOS XH7XE0 Intraductal carcinoma and lobular carcinoma in situ XH1DC5 Astroblastoma XH9WD1 Perivascular epithelioid tumour, malignant XH29P0 Aleukemic leukaemia, NOS XH60Q1 Letterer-Siwe disease XH94U0 Pituitary adenoma, NOS XH3PE9 Intraductal tubulopapillary neoplasm XH96C7 Astrocytoma, anaplastic XH60C2 Intravascular leiomyomatosis XH1UN6 Extra-adrenal paraganglioma XH80C3 Chronic leukaemia, NOS XH0YE1 Nonlipid reticuloendotheliosis XH26P7 Spindle cell oncocytoma XH8010 Endocrine mucin-producing sweat gland carcinoma in situ XH1S63 Astrocytoma, low grade XH2L80 Leiomyomatosis, NOS XH8GG7 Nonchromaffin paraganglioma XH6QV5 Subacute leukaemia, NOS XH40U7 Langerhans cell histiocytosis, disseminated XH52F6 Adrenal cortical adenoma, NOS XH1PG0 Intraepidermal epithelioma of Jadassohn XH4US4 Intraductal papilloma with lobular carcinoma in situ XH54D9 Cellular ependymoma XH1EX8 Metastasizing leiomyoma XH05Y1 Glomangiosarcoma XH1B20 Acute leukaemia, NOS XH4JD4 Histiocytic sarcoma XH6ZD0 Endometrioid adenoma, NOS XH5AU2 Trichilemmoma XH3M77 Choroid plexus carcinoma XH1EN1 Smooth muscle tumour of uncertain malignant potential XH21E6 Glomus tumour, malignant XH37U0 Acute biphenotypic leukaemia XH46Q0 True histiocytic lymphoma XH1CX5 Endometrioid adenofibroma, NOS XH6QT9 Trichoepithelioma XH44J4 Secretory carcinoma XH6E51 Clear cell ependymoma XH00B4 Smooth muscle tumour, NOS XH9YX6 Middle ear paraganglioma XH2H98 Acute bilineal leukaemia XH8J76 Langerhans cell sarcoma XH2H83 Microfollicular adenoma, NOS XH0U05 Trichofolliculoma XH7KH3 Infiltrating duct carcinoma, NOS XH8W32 Diffuse astrocytoma XH8MR2 Leiomyomatosis, peritonealis disseminata XH5521 Laryngeal paraganglioma XH3VV7 Acute mixed lineage leukaemia XH7UM7 Interdigitating dendritic cell sarcoma XH7DU3 Adenoma, intestinal type XH5L76 Pilar tumour XH9FX2 Adenocarcinoma of mammary gland type XH6UY7 Diffuse astrocytoma, low grade XH22N2 Leiomyosarcoma, cutaneous XH1493 Vagal paraganglioma XH97B7 Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1 XH8Q19 Dendritic cell sarcoma, NOS XH1Q16 Pancreatic neuroendocrine microadenoma XH9E37 Pilomatricoma, NOS XH1N58 Comedocarcinoma, NOS XH6922 Ependymoma, anaplastic XH3JF3 Composite paraganglioma XH2S51 Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged XH3ZM0 Indeterminate dendritic cell tumour XH8NK5 Oncocytic papillary cystadenoma XH05Z3 Trichogerminoma XH8MA7 Intraductal papillary adenocarcinoma with invasion XH6C35 Fibrillary astrocytoma XH9K97 Composite pheochromocytoma XH1928 Mixed phenotype acute leukaemia, B/myeloid, NOS XH1JT6 Follicular dendritic cell sarcoma XH8Y40 Null cell adenoma XH7CM2 Melanocytic matricoma XH8KR8 Papillary carcinoma of the breast XH5Y81 Gemistocytic astrocytoma XH6Q84 Myxoma, NOS XH0EW6 Paraganglioma, NOS XH4YB5 Mixed phenotype acute leukaemia, T/myeloid, NOS XH6ZR5 Follicular dendritic cell tumour XH1JL3 Plurihormonal adenoma XH3EY8 Pilar sheath acanthoma XH90W1 Intraductal papillary neoplasm with associated invasive carcinoma XH4RQ3 Glioma, malignant XH9HK9 Angiomyxoma XH4G21 Sympathetic paraganglioma XH0124 Fibroblastic reticular cell tumour XH50K4 Gonadotroph adenoma XH0489 Tumor of follicular infundibulum XH0GT6 Encapsulated papillary carcinoma with invasion XH6ZH4 Gliomatosis cerebri XH1DA7 Ossifying fibromyxoid tumour XH5LK3 Parasympathetic paraganglioma XH81V3 B lymphoblastic leukaemia/lymphoma, NOS XH75E6 Eosinophilic granuloma XH4HE3 Somatotroph adenoma XH2K97 Trichoblastoma XH9C56 Invasive micropapillary carcinoma of breast XH9RC8 Gliosarcoma XH4V74 Deep angiomyxoma XH7YU4 Aortic body tumour XH73L9 B lymphoblastic leukaemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 XH0MY4 Thyrotroph adenoma XH1XB5 Solid papillary carcinoma with invasion XH6F49 Oligoastrocytoma, NOS XH58A9 Superficial angiomyxoma XH3FS7 Carotid body paraganglioma XH8GG0 B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged XH0RF4 Langerhans cell histiocytosis, monostotic XH5RH2 Pituitary adenoma, ectopic XH70J2 Adenoid basal carcinoma XH2YP5 Medullary carcinoma, NOS XH9J28 Papillary ependymoma XH20B4 Chemodectoma XH4KA2 B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) XH2PY9 Langerhans cell histiocytosis, polyostotic XH1C58 Corticotroph adenoma XH45F3 Basal cell carcinoma, fibroepithelial XH9B99 Medullary-like carcinoma XH99U2 Pleomorphic xanthoastrocytoma XH4V76 Low grade fibromyxoid sarcoma XH3854 Pheochromocytoma, NOS XH24C7 B lymphoblastic leukaemia/lymphoma with hyperdiploidy XH1J18 Langerhans cell histiocytosis XH7743 Bronchiolar adenoma / Ciliated muconodular papillary tumour XH4GJ2 Basal cell carcinoma, micronodular XH2XR3 Lobular carcinoma, NOS XH6UV4 Protoplasmic astrocytoma XH4BT2 Sclerosing epithelioid fibrosarcoma XH2MD9 B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL) XH2CR0 Basal cell carcinoma, nodular XH9620 Medullary adenocarcinoma XH4BJ4 Tanycytic ependymoma XH3TB0 Ossifying fibromyxoid tumour, malignant XH7CP7 Glomangiomatosis XH4ZL2 B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH XH2L30 Adenocarcinoma in situ, NOS XH2615 Basal cell carcinoma, NOS XH6KZ1 Atypical medullary carcinoma XH7692 Diffuse midline glioma, H3 K27M-mutant XH51Y9 Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation XH5D10 Glomus tumor of uncertain malignant potential XH3GU8 B lymphoblastic leukaemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) XH4J07 Adenocarcinoma in situ in adenomatous polyp XH4C18 Basosquamous carcinoma XH6PY4 Duct carcinoma, desmoplastic type XH9YU2 Diffuse intrinsic pontine glioma, H3 K27M-mutant XH5WF6 Myxosarcoma XH7Q12 Lymphoid leukaemia, NOS XH3770 Adenocarcinoma in situ in tubulovillous adenoma XH5VK4 Infiltrating basal cell carcinoma, NOS XH55H7 Medullary carcinoma with lymphoid stroma XH1511 Ependymoma, NOS XH1GQ1 Lymphatic leukaemia, NOS XH8TV2 Adenocarcinoma in situ in villous adenoma XH0T12 Infiltrating basal cell carcinoma, non-sclerosing XH3RK9 Tubulolobular carcinoma XH2AY7 Ependymoma, RELA fusion-positive XH67T7 Soft tissue tumour, benign XH7PW5 Lymphocytic leukaemia, NOS XH5U91 Biliary intraepithelial neoplasia, high grade XH67Y4 Infiltrating basal cell carcinoma, sclerosing XH0408 Infiltrating ductular carcinoma XH6PH6 Astrocytoma, NOS XH5T39 Acoustic neuroma XH4KS4 Aleukemic lymphoid leukaemia XH7Y32 Cribriform carcinoma in situ XH9E93 Metatypical carcinoma XH8RN5 Infiltrating duct and lobular carcinoma XH36Y8 Cystic astrocytoma XH0U07 Ancient schwannoma XH4UM7 Sarcoma, NOS XH5BA6 Lymphosarcoma cell leukaemia XH0557 Ductal carcinoma in situ, solid type XH5NL6 Superficial basal cell carcinoma XH9Z29 Intraductal and lobular carcinoma XH2HK4 Diffuse astrocytoma, IDH-mutant XH8WW8 Cellular schwannoma XH7Y17 Sarcomatosis, NOS XH8GQ0 Subacute lymphoid leukaemia XH36M5 Oesophageal glandular dysplasia (intraepithelial neoplasia), high grade XH2HE7 Pigmented basal cell carcinoma XH6MH3 Infiltrating duct and lobular carcinoma in situ XH7HQ6 Astrocytoma, anaplastic, IDH-mutant XH75P8 Degenerated schwannoma XH7AN8 Spindle cell sarcoma XH15T2 B-cell chronic lymphocytic leukaemia/small lymphocytic lymphoma XH5161 Flat intraepithelial glandular neoplasia, high grade XH9K96 Trichilemmocarcinoma XH9551 Infiltrating lobular carcinoma and ductal carcinoma in situ XH83Y5 Polar spongioblastoma XH2GD5 Melanotic neurofibroma XH73J4 Giant cell sarcoma XH6TE2 Adult T-cell leukaemia/lymphoma (HTLV-1 positive) XH28N7 Glandular intraepithelial neoplasia, high grade XH9G49 Pilomatrical carcinoma XH8CS0 Infiltrating duct mixed with other types of carcinoma XH8BK8 Anaplastic pleomorphic xanthoastrocytoma XH87J5 Neurofibroma, NOS XH85G7 Small cell sarcoma XH6687 T-cell large granular lymphocytic leukaemia XH26M2 Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia XH6S67 Basal cell carcinoma with adnexal differentiation XH9GX4 Infiltrating duct and colloid carcinoma XH7F82 Glioblastoma, NOS XH2MJ4 Plexiform neurofibroma XH4F96 Epithelioid sarcoma XH5EN4 Chronic lymphoproliferative disorder of NK cells XH5C49 Prostatic intraepithelial neoplasia, grade III XH3DL9 Trichoblastic carcinoma XH2ST9 Infiltrating duct and cribriform carcinoma XH5571 Glioblastoma, IDH-wild type XH9XT2 Plexiform schwannoma XH6HY6 Undifferentiated sarcoma XH8TD6 Prolymphocytic leukaemia, NOS XH1FR9 Adenocarcinoma in situ of lung, non-mucinous XH8324 Trichoblastic carcinosarcoma XH3969 Infiltrating duct and mucinous carcinoma XH0MB1 Glioblastoma, primary, NOS XH9MN2 Psammomatous schwannoma XH5SN6 Desmoplastic small round cell tumour XH95H2 Prolymphocytic leukaemia, B-cell type XH6BU6 Adenocarcinoma in situ of lung, mucinous XH1JH6 Basal cell carcinoma, sarcomatoid XH1ND7 Infiltrating duct and tubular carcinoma XH3N49 Diffuse midline glioma, NOS XH98Z3 Schwannoma, NOS XH7XH3 Pleomorphic dermal sarcoma XH0DU4 Prolymphocytic leukaemia, T-cell type XH4Z68 Endometrioid intraepithelial neoplasia XH3CB4 Infiltrating lobular mixed with other types of carcinoma XH61Y5 Diffuse intrinsic pontine glioma XH27Y1 Nerve sheath tumour, NOS XH92Y0 Epithelioid sarcoma, undifferentiated XH5J37 Precursor cell lymphoblastic leukaemia, NOS XH8189 Basal cell tumour XH5SD5 Polymorphous adenocarcinoma XH4FN3 Glioblastoma, IDH mutant XH01G0 Hybrid nerve sheath tumour XH7T28 Precursor T-cell lymphoblastic leukaemia XH2QZ6 Acidophil carcinoma XH7WJ7 Proliferating trichilemmal cyst XH9G73 Inflammatory carcinoma XH17J4 Glioblastoma, secondary, NOS XH4UE6 Neuroma, NOS XH2193 Pleomorphic hyalinizing angiectatic tumour XH50W7 T lymphoblastic leukaemia/lymphoma XH5LA4 Adenocarcinoid tumour XH3E21 Paget disease, mammary XH7W59 Oligodendroglioma, NOS XH90Y8 Solitary circumscribed neuroma XH52J1 GLI1-altered epithelioid soft tissue tumor XH1D04 B lymphoblastic leukemia/lymphoma, BCR-ABL1-like XH74S1 Adenocarcinoma, NOS XH47A6 Paget disease and infiltrating duct carcinoma of breast XH7K31 Oligodendroglioma, IDH-mutant and 1p/19q co deleted XH0XF7 Perineurioma, NOS XH0KD4 B lymphoblastic leukemia/lymphoma with iAMP21 XH7QZ0 Adenocarcinoma in adenomatous polyp XH3U29 Capillary haemangioma XH70F8 Paget disease, extramammary XH9QF3 Oligodendroglioma, anaplastic, IDH mutant and 1p/19q co deleted XH3L35 Nerve sheath myxoma XH8F29 Early T-cell precursor acute lymphoblastic leukemia XH2ZH8 Adenocarcinoma in adenomatous polyposis coli XH1GU2 Cavernous haemangioma XH0C76 Paget disease and intraductal carcinoma of breast XH7CX7 Oligodendroblastoma XH9QH2 Soft tissue perineurioma XH7H87 Androblastoma, benign XH9YR3 Adenocarcinoma in multiple adenomatous polyps XH10T4 Epithelioid haemangioma XH32K6 Basal-like carcinoma of breast XH8P29 Medulloblastoma, NOS XH4BQ8 Intraneural perineurioma XH6NZ8 Sclerosing stromal tumour XH43N4 Acute erythroid leukemia XH7QB1 Adenocarcinoma in tubulovillous adenoma XH0LN3 Haemangioendothelioma, benign XH4ZU9 Adenocarcinoma of anogenital mammary-like glands XH9M38 Medulloblastoma, SHH-activated and TP53-wild type XH1UZ6 Cellular neurothekeoma XH0BG7 Sertoli cell tumour with lipid storage XH7S21 Myeloid leukaemia, NOS XH6DA5 Adenocarcinoma in villous adenoma XH0553 Intramuscular haemangioma XH5KW8 Carcinoma of male breast XH8844 Oligodendroglioma, anaplastic XH9J01 Benign Triton tumour XH7E53 Sertoli-Leydig cell tumour, well differentiated XH7LG8 Aleukemic myeloid leukaemia XH5RE1 Adenocarcinoma of anal glands XH2HR3 Racemose haemangioma XH4EK4 Endocrine mucin-producing sweat gland carcinoma XH4B47 Melanotic medulloblastoma XH0Z30 Thecoma, luteinized XH5DV4 Aleukemic monocytic leukaemia
synonyms Benign neoplasm of spinal cord benign tumour of spinal cord Benign neoplasm of cauda equina
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com